Making best practice, everyday practice

Login Register

Dyslipidaemia – getting to lower LDL targets safely

This CPD-accredited report explains how to interpret these guidelines effectively in daily clinical practice as well as spotlighting the safe and appropriate use of the novel PCSK9 inhibitors.

Read below to complete the CPD questions Dyslipidaemia – getting to lower LDL targets safely

 
ADDITIONAL READING
 

Klug EQ, Raal FJ. New cholesterol targets for patients at high or very high cardiovascular risk and the indications for PCSK9 inhibitors (Letter to the editor). S Afr Med J 2020; 110(11): 1059.
 

Do you like this? If you want to share it:

Do you like this? Share with a colleague

[DISPLAY_ULTIMATE_SOCIAL_ICONS]

Healthcare Professional Login